HCMSG - Hepatitis C Mentor & Support Group, Inc.
Search
  • About Us
    • Our Mission
    • Board of Directors
    • Medical Advisors
  • Resources
    • COVID-19
    • Harm Reduction
    • Hep C Risks
    • Hep C Facts & Stats
    • Medications and Treatments >
      • Patient Assistance Programs
    • Reading
    • Links
  • Programs/Training
    • The Circle Model >
      • THE CIRCLE Registration
      • Group and Facilitator Guide
      • Circle Sites
    • Hepatitis C Online Training
    • The Hepatitis C Education and Support Group Assistance Program
    • Healthcare Provider Training
  • Newsletter
  • Blog
  • Support Us
  • Contact Us

New York's Unusual Law Is Boosting Hepatitis C Testing

10/16/2017

1 Comment

 
WNYC News
Oct 10, 2017 · by Audrey Quinn and Aneri PattaniWhen doctors told Tina Harris that she was infected with hepatitis C, she didn’t know what to think. Other than the few commercials she’d seen on TV, Harris said she hadn’t heard much about the disease.
The 52-year-old works at a church in the Bedford Stuyvesant neighborhood of Brooklyn. She said she never used intravenous needles or had a blood transfusion – common means of transmission for hepatitis C. “I don’t know where it came from,” she said.
And she may never have found that she was infected if it weren’t for a New York state law that makes hepatitis C screening a required part of primary care for baby boomers. That law led Harris to be tested a few years ago and prompted her to seek treatment. 
The measure, which the state legislature passed in 2014, was the first of its kind in the U.S. It required health-care providers to test anybody born between 1945 and 1965 for hepatitis C. Now a new study conducted by the New York State Department of Health suggests it might be paying off.
The study found that 50 percent more patients were tested in the year following the law’s implementation. The data also showed that about 40 percent more of the patients diagnosed with hepatitis C – like Harris – received follow up care that year. 
“I would have never asked to be tested,” Harris said.
That’s a pretty common mindset among baby boomers, said Kathleen Bernock, a family nurse practitioner and clinical director of the hepatitis C program at Bedford-Stuyvesant Family Health Center. They’re at a stage in their lives where they typically don’t engage in behaviors that would put them at risk, she said.  
Harris, who Bernock has been treating since her diagnosis, is an apt example.
“She is a full-time working woman,” Bernock said. “She goes to church every Sunday. She has her family. She has absolutely no current risk factors for having hepatitis C.”
Bernock added: “I think it could very easily have been overlooked if there hadn’t been a mandate in place.” 
Hepatitis C is a contagious disease that can lead to severe liver damage and sometimes death. About 3 million Americans – most of them baby boomers – have chronic hepatitis C, according to the federal Centers for Disease Control and Prevention. 
City data show that in New York the number is nearly 150,000 residents. But researchers say the total is likely higher primarily because as many as 75 percent of people who are infected don’t know it, according to the CDC.
The disease is typically spread by blood contact from sharing needles to inject drugs, for example, or from having undergone blood transfusions before 1992. That’s when sensitive tests for hepatitis C were introduced for blood screening. All of which means baby boomers are at an increased risk. 
In fact, baby boomers are five times more likely than any other generation to have hepatitis C, the CDC says. It’s why it’s so important for them to be tested, Bernock said.
By the time Harris was screened a few years ago, the disease had already damaged her liver. She had to start a regular course of medication, have blood drawn every two weeks and attend counseling to understand the implications of the disease.
Her treatment was covered by insurance. Not everyone is so lucky. A standard 12-week course of hepatitis C drugs can cost up to $90,000. 
In August, the federal Food and Drug Administration approved Mavyret,  a new drug with a lower price tag and a shorter treatment period: about $26,000 for an 8-week course. That can still put the drug out of reach for patients.
New York state’s Medicaid program lifts the burden for some. In the third quarter of 2015, the state spent at least $107 million on hepatitis C drugs, accounting for roughly 10 percent of all Medicaid drug spending, POLITICO reported.

TO CONTINUE READING:http://www.wnyc.org/story/new-yorks-unusual-law-is-boosting-hepatitis-c-testing/

1 Comment
vex3game.com link
10/19/2017 12:57:09 am

I was very impressed by this post, this site has always been pleasant news. Thank you very much for such an interesting post. Keep working, great job!

Reply

Your comment will be posted after it is approved.


Leave a Reply.

    Archives

    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012
    February 2012
    January 2012
    December 2011
    November 2011
    October 2011
    September 2011
    August 2011
    July 2011
    June 2011
    May 2011

    Categories

    All

    RSS Feed

Privacy Policy